Collection of Tissue, Blood, and Other Specimens From Patients With Head and Neck Diseases to Study the Causes, Diagnosis, Prevention and Treatment of Cancers
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Head and Neck Cancers
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 1468
- Locations
- 1
- Primary Endpoint
- Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future.
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
Detailed Description
This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes.
- •Patients will be entered onto this protocol without preference for any racial or ethnic group.
- •Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy.
- •The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded.
Exclusion Criteria
- •Patients not giving informed consent will be excluded.
Outcomes
Primary Outcomes
Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future.
Time Frame: 36 months